Posterior Reversible Encephalopathy Syndrome and Fatal Cryptococcal Meningitis After Immunosuppression in a Patient With Elderly Onset Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Posterior Reversible Encephalopathy Syndrome and Fatal Cryptococcal Meningitis After Immunosuppression in a Patient With Elderly Onset Inflammatory Bowel Disease

Published:2016 Issue:1 Volume:3 Page:e98
ISSN:2326-3253
Container-title:ACG Case Reports Journal
language:en
Short-container-title:

Author:

Vasant Dipesh H.,Limdi Jimmy K.,Borg-Bartolo Simon P.,Bonington Alec,George Regi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference15 articles.

1. Systematic review and metaanalysis: Opportunistic infections and malignancies during treatment with anti-integrin antibodies in inflammatory bowel disease.;Luthra;Aliment Pharmacol Ther,2015

2. Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease.;Lobaton;Aliment Pharmacol Ther,2015

3. Posterior reversible encephalopathy syndrome following infliximab infusion.;Zamvar;J Pediatr Gastroenterol Nutr,2009

4. A case of posterior reversible encephalopathy syndrome in a child with Crohns disease treated with infliximab.;Haddock;J Crohns Colitis,2011

5. Infliximab-related seizures: A first case study.;Brigo;Epileptic Disord,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cryptococcosis Associated With Biologic Therapy: A Narrative Review;Open Forum Infectious Diseases;2024-06-26

2. Pulmonary cryptococcosis after immunomodulator treatment in patients with Crohn’s disease: Three case reports;World Journal of Gastroenterology;2023-01-28

3. Simultaneous Development of Progressive Multifocal Leukoencephalopathy and Cryptococcal Meningitis during Methotrexate and Infliximab Treatment;Internal Medicine;2019-09-15

4. Posterior reversible encephalopathy syndrome (PRES) and infection: a systematic review of the literature;Neurological Sciences;2019-01-02

5. Infliximab/prednisolone;Reactions Weekly;2016-12